With the increased popularity of the decentralized and hybrid models of clinical trials come unique challenges, especially regarding investigational device management and training execution. In this new MEDIcept White Paper, the importance of supply and training management in Decentralized Clinical Trials (DCTs) is discussed.
Unlike traditional trials, DCTs require devices to be shipped directly to participants' homes, necessitating remote device training for participants. This article provides strategies for effective supply management and training in DCTs and highlights the key differences between traditional trials and DCTs. The success of DCTs depends on a successful supply management system and effective training management.
To learn more, click to read the latest MEDIcept White Paper written by Associate Consultant, Quality Systems, Calia Harakaly